{
    "clinical_study": {
        "@rank": "134488", 
        "arm_group": {
            "arm_group_label": "RoActemra/Actemra", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This open-label, multicenter study will evaluate the pharmacokinetics, pharmacodynamics and\n      safety of subcutaneously administered RoActemra/Actemra (tocilizumab) in patients with\n      polyarticular-course juvenile idiopathic arthritis. Patients will receive RoActemra/Actemra\n      subcutaneously every 2 or 3 weeks for 52 weeks."
        }, 
        "brief_title": "A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Juvenile Idiopathic Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Juvenile Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ages 1 year up to and including 17 years at screening\n\n          -  Diagnosis of polyarticular-course juvenile idiopathic arthritis according to\n             International League of Associations for Rheumatology classification\n\n               -  Rheumatoid factor (RF)-positive polyarticular JIA (pJIA)\n\n               -  RF-negative pJIA\n\n               -  Extended oligoarticular JIA with a polyarticular course\n\n          -  History of inadequate clinical response (in the opinion of the treating physician) to\n             or inability to tolerate methotrexate (MTX)\n\n          -  If a patient has received previous treatment with any biologic agents other than TCZ\n             (tocilizumab), these must have been discontinued according to the timelines defined\n             by protocol prior to the baseline visit\n\n          -  Patients currently receiving TCZ by the IV route of administration and with\n             well-controlled disease do not require a period of discontinuation of IV TCZ and\n             should have their first dose of SC TCZ administered on the date that their next IV\n             TCZ infusion would be due.\n\n          -  Concurrent treatment with DMARDs (including MTX), NSAIDs, and oral corticosteroids\n             are permitted at the discretion of the investigator.\n\n          -  Females of childbearing potential and non-sterile males with female partner of\n             childbearing potential must agree to use effective contraception as defined by\n             protocol\n\n        Exclusion Criteria:\n\n          -  Prior discontinuation of IV TCZ because of inadequate clinical response or safety\n             events (including hypersensitivity)\n\n          -  Patients with poorly controlled disease (in the opinion of the treating physician)\n             despite current treatment with IV TCZ\n\n          -  pcJIA that is well controlled by any treatment agent other than TCZ (Juvenile\n             Arthritis Disease Activity Score [JADAS]-71 < / = 3.8)\n\n          -  Patients who are wheelchair-bound or bedridden\n\n          -  Any other auto-immune, rheumatic disease, or overlapping syndrome other than the\n             permitted pcJIA subsets\n\n          -  Lack of recovery from recent surgery or an interval of < 6 weeks since surgery at the\n             time of the screening visit\n\n          -  Females who are pregnant, lactating, or intending to become pregnant during study\n             conduct\n\n          -  Any significant concurrent medical or surgical condition that would jeopardize the\n             patient's safety or ability to complete the study\n\n          -  Known HIV infection or other acquired forms of immune compromise or inborn conditions\n             characterized by a compromised immune system\n\n          -  History of alcohol, drug, or chemical abuse within 6 months of screening\n\n          -  Any active acute, subacute, chronic, or recurrent bacterial, viral, or systemic\n             fungal infection or any major episode of infection requiring hospitalization or\n             treatment during screening or treatment with IV antibiotics completed within 4 weeks\n             of the screening visit or oral antibiotics completed within 2 weeks of the screening\n             visit\n\n          -  History of atypical tuberculosis (TB) or active TB requiring treatment within 2 years\n             prior to screening visit\n\n          -  Positive TB test at screening unless treated with anti-TB therapy for at least 4\n             weeks prior to receiving study drug\n\n          -  History of reactivation or new onset of a systemic infection such as herpes zoster or\n             Epstein-Barr virus within 2 months of the screening visit\n\n          -  Hepatitis B surface antigen or hepatitis C antibody positivity or chronic viral or\n             autoimmune hepatitis\n\n          -  History of concurrent serious gastrointestinal disorders such as ulcer or\n             inflammatory bowel disease, Crohn's disease, ulcerative colitis, or other symptomatic\n             lower gastrointestinal conditions\n\n          -  History of or current cancer or lymphoma\n\n          -  Uncontrolled diabetes mellitus with elevated glycosylated hemoglobin\n\n          -  Active uveitis at screening\n\n          -  Inadequate hematologic, renal or liver function"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01904279", 
            "org_study_id": "WA28117"
        }, 
        "intervention": {
            "arm_group_label": "RoActemra/Actemra", 
            "description": "Subcutaneous doses every 2 or 3 weeks for 52 weeks", 
            "intervention_name": "tocilizumab [RoActemra/Actemra]", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 19, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Hartford", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06106"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60637"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hackensack", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07601"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28203"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45229-3039"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tulsa", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "74135"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84109"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98105"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina", 
                        "zip": "1270"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Westmead", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2145"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Parkville", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3052"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rio de Janeiro", 
                        "country": "Brazil", 
                        "state": "RJ", 
                        "zip": "20551-030"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rio de janeiro", 
                        "country": "Brazil", 
                        "state": "RJ", 
                        "zip": "20530-310"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sao Paulo", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "05403-000"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sao Paulo", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "22793-080"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Calgary", 
                        "country": "Canada", 
                        "state": "Alberta", 
                        "zip": "T3B 6A8"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ottawa", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "K1H 8L1"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 1X8"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Kremlin Bic\u00eatre", 
                        "country": "France", 
                        "zip": "94275"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75743"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Freiburg", 
                        "country": "Germany", 
                        "zip": "79106"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sankt Augustin", 
                        "country": "Germany", 
                        "zip": "53757"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "state": "Lazio", 
                        "zip": "00165"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Genova", 
                        "country": "Italy", 
                        "state": "Liguria", 
                        "zip": "16147"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "state": "Toscana", 
                        "zip": "50139"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Monterrey", 
                        "country": "Mexico", 
                        "zip": "64460"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "119991"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "115522"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Esplugas de Llobregat", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08950"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28046"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28034"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bristol", 
                        "country": "United Kingdom", 
                        "zip": "BS2 8BJ"
                    }
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Liverpool", 
                        "country": "United Kingdom", 
                        "zip": "L12 2AP"
                    }
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Argentina", 
                "Australia", 
                "Brazil", 
                "Canada", 
                "France", 
                "Germany", 
                "Italy", 
                "Mexico", 
                "Russian Federation", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "AN PHASE Ib, OPEN LABEL, MULTICENTER STUDY TO INVESTIGATE THE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF TOCILIZUMAB FOLLOWING SUBCUTANEOUS ADMINISTRATION IN PATIENTS WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS", 
        "overall_contact": {
            "email": "global.rochegenentechtrials@roche.com", 
            "last_name": "Reference Study ID Number: WA28117 www.roche.com/about_roche/roche_worldwide.htm", 
            "phone": "888-662-6728 (U.S. Only)"
        }, 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Pharmacokinetics: Area under the concentration-time curve (AUC)", 
                "safety_issue": "No", 
                "time_frame": "14 weeks"
            }, 
            {
                "measure": "Pharmacokinetics: Serum concentrations (Cmin/Cmax)", 
                "safety_issue": "No", 
                "time_frame": "14 weeks"
            }
        ], 
        "removed_countries": {
            "country": [
                "Poland", 
                "Peru"
            ]
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01904279"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Pharmacodynamics: Serum interleukin-6 (IL6)/soluble IL-6 receptor (sIL-6R) levels", 
                "safety_issue": "No", 
                "time_frame": "14 weeks"
            }, 
            {
                "measure": "Pharmacodynamics: C-reactive protein (CRP)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "measure": "Pharmacodynamics: Erythrocyte sedimentation rate (ESR)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "measure": "Pharmacodynamics: Incidence of anti-TCZ antibodies", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "measure": "Safety: Incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "57 weeks"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}